GB9929772D0 - New use - Google Patents

New use

Info

Publication number
GB9929772D0
GB9929772D0 GBGB9929772.3A GB9929772A GB9929772D0 GB 9929772 D0 GB9929772 D0 GB 9929772D0 GB 9929772 A GB9929772 A GB 9929772A GB 9929772 D0 GB9929772 D0 GB 9929772D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9929772.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9929772.3A priority Critical patent/GB9929772D0/en
Publication of GB9929772D0 publication Critical patent/GB9929772D0/en
Priority to AU31587/01A priority patent/AU3158701A/en
Priority to PCT/EP2000/012703 priority patent/WO2001043759A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB9929772.3A 1999-12-16 1999-12-16 New use Ceased GB9929772D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9929772.3A GB9929772D0 (en) 1999-12-16 1999-12-16 New use
AU31587/01A AU3158701A (en) 1999-12-16 2000-12-12 New use
PCT/EP2000/012703 WO2001043759A2 (en) 1999-12-16 2000-12-12 Use of 11cby popypeptides and polynuceotides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9929772.3A GB9929772D0 (en) 1999-12-16 1999-12-16 New use

Publications (1)

Publication Number Publication Date
GB9929772D0 true GB9929772D0 (en) 2000-02-09

Family

ID=10866456

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9929772.3A Ceased GB9929772D0 (en) 1999-12-16 1999-12-16 New use

Country Status (3)

Country Link
AU (1) AU3158701A (en)
GB (1) GB9929772D0 (en)
WO (1) WO2001043759A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US7078187B2 (en) 2001-04-19 2006-07-18 Neurogen Corporation Melanin concentrating hormone receptors
US7078484B2 (en) 2001-04-19 2006-07-18 Neurogen Corporation Melanin concentrating hormone receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336678C (en) * 1988-09-13 1995-08-15 David L. Berliner Prophylaxis and treatment of nervous system diseases with melanin
EP0848060A3 (en) * 1996-12-11 2000-02-02 Smithkline Beecham Corporation Novel human 11CB splice variant
WO1999028492A1 (en) * 1997-12-03 1999-06-10 Smithkline Beecham Corporation A method of finding agonist and antagonist to human 11cb splice variant
AU6035999A (en) * 1998-09-17 2000-04-03 Incyte Pharmaceuticals, Inc. Human gpcr proteins
WO2000049170A1 (en) * 1999-02-18 2000-08-24 Smithkline Beecham Corporation MURINE 11cby RECEPTOR

Also Published As

Publication number Publication date
WO2001043759A2 (en) 2001-06-21
WO2001043759A3 (en) 2002-05-30
AU3158701A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
IL149617A0 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
IL148218A0 (en) New phenylpiperazines
IL145995A0 (en) Use
GB9913536D0 (en) Use
DE60044740D1 (en) Hochtemperatur-differentialrefraktometer
DE60037536D1 (en) Polypeptidhormon phosphatonin
AU141428S (en) Turnpiece
GB9919971D0 (en) Use
GB9918851D0 (en) Flamelight
GB9929772D0 (en) New use
GB9929668D0 (en) Microclamps
GB9916014D0 (en) Ladder-stay
GB2356170B (en) Cardlet
AU140373S (en) Bumbag
PL341191A1 (en) Glass-furnace
GB9930100D0 (en) New use
GB9915473D0 (en) New use
GB9928329D0 (en) New use
GB9928339D0 (en) New Use
GB9907261D0 (en) New use
GB9918781D0 (en) Multibin
GB9914278D0 (en) Instantent
GB9910166D0 (en) Use
GB9903265D0 (en) Novel use
GB9903282D0 (en) Novel use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)